CCA Industries sells Mega-T brand to a group formed by Casla Partners

CCA Industries, Inc. (NYSE MKT: "CAW") announced today that it has sold its weight loss business, marketed under the Mega-T brand, to a group formed by Casla Partners Capital Fund I, LP.

Under the terms of the sale, the purchaser received all inventory, trademarks and other intellectual property rights related to the brand in exchange for assuming pre-closing liabilities for returns, markdowns and co-operative advertising deductions by the retailers up to a cap of $2,250,000. The Company does not believe that these pre-closing liabilities will exceed the $2,250,000 cap.

Richard Kornhauser, Chief Executive Officer and President of CCA commented, "The sale of the Mega-T brand represents an important step in strengthening our Company's future performance by enabling us to focus resources behind our five core brands: Bikini Zone, Nutra Nail Treatments, Plus White, Scar Zone, and Sudden Change. This transaction also relieves the Company of a significant financial liability and allows the Company to better support its brand advertising program to deliver new sales and profits." Mr. Kornhauser added, "We believe that Mega-T is in the hands of capable and experienced weight loss category managers and we wish them the very best in their future endeavors." 

"Casla is excited to add the Mega-T brand to its growing portfolio of investments, an acquisition that builds on the firm's demonstrated core competency of acquiring, integrating, and growing high equity businesses," said Jared Rochwerg, a partner of Casla. "Mega-T possesses strong brand equity and consumer awareness, while the efficacy of its products contribute to a healthy and active lifestyle. With the firm's proven operational and marketing expertise in the space, Casla is the optimal partner to support Mega-T in realizing its growth potential," added Mr. Rochwerg.

Source:

CCA Industries, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Anti-obesity drugs show promise in improving cardiovascular health beyond weight loss